Current concepts in the management of uveitic macular edema

Johns Hopkins Advanced Studies in Ophthalmology

Volumn 7, Issue 2, 2010, Pages 60-66

  Davis, Janet ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; BEVACIZUMAB; DEXAMETHASONE; FLUOCINOLONE; FLUOCINOLONE ACETONIDE; FLUOROMETHOLONE; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; LOTEPREDNOL ETABONATE; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OCTREOTIDE; PEGAPTANIB; PREDNISONE; RANIBIZUMAB; RIMEXOLONE; TRIAMCINOLONE; TRIAMCINOLONE ACETONIDE;

ARTICLE; FLUORESCENCE; FOLLOW UP; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MEDLINE; MULTICENTER STUDY (TOPIC); OPTICAL COHERENCE TOMOGRAPHY; OUTCOME ASSESSMENT; PHASE 3 CLINICAL TRIAL (TOPIC); RETINA MACULA EDEMA; UVEITIS; VISUAL ACUITY; VITRECTOMY;

EID: 80052072488     PISSN: 15580199     EISSN: 15580202     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Whitcup SM, Csaky KG, Pdogor MJ, et al. A randomized, masked, cross-over trial of acetazolamide for cystoid macu-lar edema in patients with uveitis. Ophthalmology. 1996;103:1054-1062.
2. Spaide R F, Yannuzzi LA, Sisco LJ. Chronic cystoid macular edema and predictors of visual acuity. Opthalmic Surg. 1993;24:262-267.
3. Nussenblatt RB, Kaufman SC, Palestine AG, et al. Macular thickening and visual acuity. Measurement in patients with cys-toid macular edema. Ophthalmology. 1987;94:1134-1139.
4. Roesel M, Henschel A, Heinz C, et al. Fundus autofluores-cence and spectral domain optical coherence tomography in uveitic macular edema. Graefes Arch Clin Exp Ophthalmol. 2009;24:1685-1689.
5. Lardenoye CW, van Kooij B, Rothova A. Impact of macular edema on visual acuity in uveitis. Opthalmology. 2006;113:1446-1449.
6. van Kooij B, Probst K, Finjheer R, et al. Risk factors for cys-toid macular oedema in patients with uveitis. Eye. 2008;22:256-260.
7. Lin P, Loh AR, Margolis T P, Acharya NR. Cigarette smoking as a risk factor for uveitis. Ophthalmology. 2010;117:585-590.
8. Becker M, Davis J. Vitrectomy in the treatment of uveitis. Am J Ophthalmol. 2005;140:1096-1105.
9. Venkatesh P, Kumar CS, Abbas Z, Garg S. Comparison of the efficacy and safety of different methods of posterior subtenon injection. Ocul Immunol Inflamm. 2008;16:217-223.
10. Kok H, Lau C, Maycock N, McCluskey P, Lightman S. Outcome of intravitreal triamcinolone in uveitis. Ophthalmology. 2005;112:1916.e1-7.
11. Das-Bhaumik RG, Jones NP. Low-dose intraocular triamci-nolone injection for intractable macular oedema and inflammation in patients with uveitis. Eye. 2006;20:934-937.
12. Angunawela RI, Heatley CJ, Williamson TH, et al. Intravitreal triamcinolone acetonide for refractory uveitic cys-toid macular oedema: longterm management and outcome. Acta Ophthalmol Scand. 2005;83:595-599.
13. Atmaca LS, Yalcindag FN, Ozdemir O. Intravitreal triamci-nolone acetonide in the management of cystoid macular edema in Behçet's disease. Graefes Arch Clin Exp Ophthalmol. 2007;245:451-456.
14. Dong Z, Namba K, Kitaichi N, et al. Efficacy and complications of intravitreal injection of triamcinolone acetonide for refractory cystoid macular edema associated with intraocular inflammation. Jpn J Ophthalmol. 2008;52:374-379.
15. Hogewind B F, Zijlstra C, Klevering BJ, Hoyng CB. Intravitreal triamcinolone for the treatment of refractory mac-ular edema in idiopathic intermediate or posterior uveitis. Eur J Ophthalmol. 2008;18:429-434.
16. Maca SM, Abela-Formanek C, Kiss CG, et al. Intravitreal triamcinolone for persistent cystoid macular oedema in eyes with quiescent uveitis. Clin Experiment Ophthalmol. 2009;37:389-396.
17. Callanan DG, Jaffe GJ, Martin D F, et al. Treatment of posterior uveitis with a fluocinolone acetonide implant: three-year clinical trial results. Arch Ophthalmol. 2008;126:1191-1201.
18. Pavesio C, Zierhut M, Bairi K, et al. Evaluation of an intrav-itreal fluocinolone acetonide implant versus standard systemic therapy in non-infectious posterior uveitis. Ophthalmology. 2010;117;567-55.
19. Deuter CM, Kotter I, Gunaydin I, et al. Efficacy and tolera-bility of interferon alpha treatment in patients with chronic cystoid macular oedema due to non-infectious uveitis. Br J Ophthalmol. 2009;93:906-913.
20. Acharya NR, Hong KC, Lee SM. Ranibizumab for refractory uveitis-related macular edema. Am J Ophthalmol. 2009;148;303-309.
21. Cervantes-Castaneda RA, Giullari G P, Gallagher MJ, et al. Intravitreal bevacizumab in refractory uveitic macular edema: one-year follow-up. Eur J Ophthalmol. 2009;19:622-629.
22. Markomichelakis NN, Theodossiadis PG, Pantelia E, et al. Infliximab for chronic cystoid macular edema associated with uveitis. Am J Ophthalmol. 2004;138:648-650.
23. Neir P, Mariotti C, Cimino L, et al. Long-term control of cys-toid macular oedema in noninfectious uveitis with mycophe-nolate mofetil. Int Ophthalmol. 2009;29:127-133.
24. Schilling H, Heiligenhaus A, Laube T, et al. Long-term effect of acetazolamide treatment of patients with uveitic chronic cystoid macular edema is limited by persisting inflammation. Retina. 2005;25:182-188.
25. Taylor SR, Habot-Wilner Z, Pacheco P, Lightman SL. Intraocular methotrexate in the treatment of uveitis and uveitic cystoid macular edema. Ophthalmology. 2009;116:797-801.
26. Gutfleisch M, Spital G, Mingels A, et al. Pars plana vitrec-tomy with intravitreal triamcinolone: effect on uveitic cystoid macular oedema and treatment limitations. Br J Ophthalmol. 2007;91:345-348.
27. Tranos P, Scott R, Zambarakji H, et al. The effect of pars plana vitrectomy on cystoid macular oedema associated with chronicuveitis: a randomized, controlled pilot study. Br J Ophthalmol. 2006;90:1107-1110.
28. Androudi S, Letko E, Meniconi M, et al. Safety and efficacy of intravitreal triamcinolone acetonide for uveitic macularedema. Ocul Immunol Inflamm. 2005;13:205-212.